351 related articles for article (PubMed ID: 33587283)
1. Eczematous Drug Eruptions.
Blum AE; Burgin S
Am J Clin Dermatol; 2021 May; 22(3):349-366. PubMed ID: 33587283
[TBL] [Abstract][Full Text] [Related]
2. Management of refractory telaprevir-induced dermatitis using oral corticosteroids.
Garcias-Ladaria J; Pérez-Ferriols A; Ortega-García P; Diago M
Actas Dermosifiliogr; 2014 Nov; 105(9):e55-60. PubMed ID: 24786187
[TBL] [Abstract][Full Text] [Related]
3. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
Corazza M; Mantovani L; Montanari A; Virgili A
J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
[TBL] [Abstract][Full Text] [Related]
4. Eczema conditions in the older person.
Sutherland M
Br J Community Nurs; 2018 Jun; 23(6):234-238. PubMed ID: 29799784
[No Abstract] [Full Text] [Related]
5. [Systemic eczematous contact type dermatitis].
Aquilina C; Sayag J
Ann Dermatol Venereol; 1989; 116(10):753-65. PubMed ID: 2575363
[No Abstract] [Full Text] [Related]
6. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.
Mistry N; Shapero J; Crawford RI
Can J Gastroenterol; 2009 Oct; 23(10):677-83. PubMed ID: 19826642
[TBL] [Abstract][Full Text] [Related]
7. [Contact allergy for corticosteroids].
de Groot AC; van Ginkel CJ; Bruynzeel DP
Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1559-62. PubMed ID: 9543750
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Eczema: Corticosteroids and Beyond.
Chong M; Fonacier L
Clin Rev Allergy Immunol; 2016 Dec; 51(3):249-262. PubMed ID: 25869743
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced exanthema caused by pegylated interferon-alpha 2b].
Meller S; Erhardt A; Auci A; Neumann NJ; Homey B
Hautarzt; 2003 Oct; 54(10):992-3. PubMed ID: 14513254
[No Abstract] [Full Text] [Related]
10. Allergic contact eczema from topical corticosteroids.
Förström L; Lassus A; Salde L; Niemi KM
Contact Dermatitis; 1982 Mar; 8(2):128-33. PubMed ID: 6461499
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study.
Noorily AR; Criscito MC; Cohen JM; Brinster NK
Am J Dermatopathol; 2021 Feb; 43(2):112-118. PubMed ID: 32618707
[TBL] [Abstract][Full Text] [Related]
12. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME; Goleva E; Shah N; Rotemberg V; Kraehenbuehl L; Ketosugbo KF; Merghoub T; Maier T; Bang A; Gu S; Salvador T; Moy AP; Lyubchenko T; Xiao O; Hall CF; Berdyshev E; Crooks J; Weight R; Kern JA; Leung DYM
Clin Cancer Res; 2024 Jul; 30(13):2822-2834. PubMed ID: 38652814
[TBL] [Abstract][Full Text] [Related]
13. Type IV reactions in the skin.
Weston WL
Ann Allergy; 1976 Nov; 37(5):346-52. PubMed ID: 793453
[TBL] [Abstract][Full Text] [Related]
14. Systemic eczematous contact dermatitis due to the ethylenediamine fraction of aminophylline.
Vázquez Botet M
Bol Asoc Med P R; 1980 Jan; 72(1):14-8. PubMed ID: 6444820
[No Abstract] [Full Text] [Related]
15. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
Tavakoli-Tabasi S; Bagree A
J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
[TBL] [Abstract][Full Text] [Related]
16. The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.
Pach J; Valido K; Belzer A; Leventhal JS
Am J Clin Dermatol; 2024 Jul; 25(4):595-607. PubMed ID: 38767827
[TBL] [Abstract][Full Text] [Related]
17. [Baboon syndrome].
Oehler E; Eftekari-Hassanlouie S; Le Guern A
Rev Prat; 2014 Dec; 64(10):1348. PubMed ID: 25665308
[No Abstract] [Full Text] [Related]
18. Leucocytic migration in vitro as an indicator of allergy in eczematous contact dermatitis.
Nordqvist B; Rorsman H
Trans St Johns Hosp Dermatol Soc; 1967; 53(2):154-9. PubMed ID: 4231607
[No Abstract] [Full Text] [Related]
19. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.
Caldarola G; Pirro F; Di Stefani A; Talamonti M; Galluzzo M; D'Adamio S; Magnano M; Bernardini N; Malagoli P; Bardazzi F; Potenza C; Bianchi L; Peris K; De Simone C
Expert Opin Biol Ther; 2020 Jun; 20(6):665-672. PubMed ID: 32045273
[No Abstract] [Full Text] [Related]
20. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers.
Summers EM; Bingham CS; Dahle KW; Sweeney C; Ying J; Sontheimer RD
JAMA Dermatol; 2013 Jul; 149(7):814-8. PubMed ID: 23636109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
